Biotricity, Inc. (BTCY)
OTCMKTS · Delayed Price · Currency is USD
0.6229
-0.0051 (-0.81%)
Sep 18, 2025, 3:30 PM EDT
Biotricity Market Cap
Biotricity has a market cap or net worth of $16.79 million as of September 18, 2025. Its market cap has increased by 79.09% in one year.
Market Cap
16.79M
Enterprise Value
45.35M
Revenue
14.46M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.62
Market Cap Chart
Since February 18, 2016, Biotricity's market cap has decreased from 187.13M to 16.79M, a decrease of -91.03%. That is a compound annual growth rate of -22.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 16.79M | 135.84% |
| Dec 31, 2024 | 7.12M | -31.33% |
| Dec 29, 2023 | 10.37M | -61.10% |
| Dec 30, 2022 | 26.65M | -88.14% |
| Dec 31, 2021 | 224.72M | 464.80% |
| Dec 31, 2020 | 39.79M | 13.76% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Feb 18, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 806.69M |
| Tian'an Technology Group | 792.01M |
| Elite Pharmaceuticals | 718.26M |
| Glass House Brands | 574.70M |
| CytoDyn | 377.06M |
| Northwest Biotherapeutics | 373.88M |
| American Oncology Network | 345.48M |